About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acasti Pharma (NQ: ACST )

3.370 UNCHANGED
Last Price Updated: 3:44 PM EDT, Oct 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acasti Pharma

< Previous 1 2 3 Next >
Stocks That Hit 52-Week Lows On Monday
  Monday saw 33 companies set new 52-week lows. 
Via Benzinga
Acasti Pharma Reports Second Quarter 2023 Operational Results
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma to Present at Q4 Investor Summit
From Acasti Pharma, Inc.
Via GlobeNewswire
Recap: Acasti Pharma Q4 Earnings
Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 stocks hit new 52-week lows. 
Via Benzinga
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
Call to be held on Monday, November 14th at 1:00 PM Eastern Time 
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma Inc. (NASDAQ:ACST) (TSX.V:ACST) Featured in Coverage of Investor Summit Group’s Q4 Event
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Acasti Announces Court Dismissal of Stockholder Litigation
From Acasti Pharma, Inc.
Via GlobeNewswire
121 Stocks That Hit Their 52-Week Low
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
Via Benzinga
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - September 21, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),... 
Via Newsfile
Exposures Product Safety
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - July 7, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),... 
Via Newsfile
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For June 21, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its first quarter. 
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
From MicroCap Rodeo
Via AccessWire
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th
LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D'Alvise, Chief Executive Officer, has been invited to present... 
From Acasti Pharma Inc.
Via AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, trader! We're starting off another week of trading with an overview of the biggest pre-market stock mover for Monday! 
Via InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday. 
Via Benzinga
Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 22, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),... 
Via Newsfile
Acasti Pharma's Earnings Outlook
Acasti Pharma (NASDAQ:ACST) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Acasti Pharma... 
Via Benzinga
Acasti Pharma: Bouncing Back With a New Drug Pipeline
Picture credit: Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... 
Via Benzinga
Earnings Scheduled For February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. 
Via Benzinga
BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today
i3 Interactive (BLITF) stock is rising higher on heavy trading Thursday despite a lack of news from the mobile gambling company. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.